Effect of pharmacologic conditioning on sulfadiazine toxicity and concentrations in plasma.
D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000737:Androstenols / Q000494:pharmacology; D000818:Animals; D003864:Depression, Chemical; D003900:Desoxycorticosterone / Q000494:pharmacology; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D007664:Ketosteroids / Q000494:pharmacology; D007668:Kidney / Q000033:anatomy & histology / Q000187:drug effects; D009929:Organ Size; D010634:Phenobarbital / Q000494:pharmacology; D011239:Prednisolone / Q000494:pharmacology; D011277:Pregnanediones / Q000494:pharmacology; D011285:Pregnenolone Carbonitrile / Q000494:pharmacology; D011422:Propionates / Q000494:pharmacology; D051381:Rats; D013148:Spironolactone / Q000494:pharmacology; D013268:Stimulation, Chemical; D013411:Sulfadiazine / Q000097:blood / Q000633:toxicity*; D013974:Thyroxine / Q000494:pharmacology; D014221:Triamcinolone / Q000494:pharmacology
D000737:Androstenols; D007664:Ketosteroids; D011277:Pregnanediones; D011422:Propionates; D013411:Sulfadiazine; D011285:Pregnenolone Carbonitrile; D014221:Triamcinolone; D013148:Spironolactone; D003900:Desoxycorticosterone; D004958:Estradiol; D000324:Adrenocorticotropic Hormone; D011239:Prednisolone; D013974:Thyroxine; D010634:Phenobarbital